LINCO-SPECTIN (50+100)MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
LINCO-SPECTIN (50+100)MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Spectinomycin sulfate
- Lincomycin hydrochloride
Product identification
Medicine name:
LINCO-SPECTIN (50+100)MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Spectinomycin sulfate
- Lincomycin hydrochloride
Target species:
-
Sheep
-
Goat
-
Cattle (calf)
-
Pig
-
Chicken
-
Turkey
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Spectinomycin sulfate100.00/milligram(s)1.00millilitre(s)
-
Lincomycin hydrochloride50.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Sheep
-
Meat and offal14day
-
Milk2day
-
-
Goat
-
Meat and offal14day
-
Milk2day
-
-
Cattle (calf)
-
Meat and offal14day
-
Milk2day
-
-
Pig
-
Meat and offal14day
-
-
Chicken
-
Meat and offal14day
-
-
Turkey
-
Meat and offal14day
-
-
Dog
-
Not applicableno withdrawal period
-
-
Cat
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium SA
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 56768/16-06-2021/K-0015804
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: